Silverwood Partners
  • About Us
    • Overview
    • Why Silverwood?
    • Careers
    • Our Location
    • Connect With Us
  • Insights & Analysis
    • Newsletters
    • Intelligence Briefs
    • Events
    • Connect With Us
  • Team
    • All Team
    • Technology
    • Consumer
    • Healthcare
  • Industry Experience
    • Technology
    • Consumer
    • Healthcare
    • Connect With Us
  • Services
    • Mergers & Acquisitions
    • Private Placements
    • Connect With Us
  • Transactions
    • All Transactions
    • Technology
    • Consumer
    • Healthcare
    • Connect With Us
Select Page
Healthcare Private Placement and M&A Transactions Review Week Ending January 29 2023

Healthcare Private Placement and M&A Transactions Review Week Ending January 29 2023

by Jonathan Hodson-Walker | Feb 1, 2023 | Healthcare

Strategy | Financing Highlight  Private Placement / Financing Transactions Alleviant Medical: The company raised $75 million of venture funding in a deal led by S3 Ventures and RiverVest Venture Partners on January 26, 2023. Vensana Capital, Gilmartin Capital,...
Healthcare Private Placement and M&A Transactions Review Week Ending January 22 2023

Healthcare Private Placement and M&A Transactions Review Week Ending January 22 2023

by Jonathan Hodson-Walker | Jan 25, 2023 | Healthcare

Strategy | Financing Highlight  Private Placement / Financing Transactions ADARx Pharmaceuticals: The company raised $46 million of Series B1 venture funding in a deal led by Ascenta Capital on January 20, 2023. Lilly Asia Ventures, OrbiMed, SR One, and Sirona Capital...
Healthcare Private Placement and M&A Transactions Review Week Ending January 15 2023

Healthcare Private Placement and M&A Transactions Review Week Ending January 15 2023

by Jonathan Hodson-Walker | Jan 18, 2023 | Healthcare

Strategy | Financing Highlight  Private Placement / Financing Transactions Carbon Health: The company raised $100 million of Series D-2 venture funding in a deal led by CVS Health Ventures on January 9, 2023, putting the company’s pre-money valuation at $1.3...
Healthcare Private Placement and M&A Transactions Review Week Ending January 8 2023

Healthcare Private Placement and M&A Transactions Review Week Ending January 8 2023

by Jonathan Hodson-Walker | Jan 10, 2023 | Healthcare

Strategy | Financing Highlight  Private Placement / Financing Transactions Synthekine: The company raised $100 million of Series C venture funding in a deal led by The Column Group on January 6, 2023. The company is a developer of engineered cytokine therapeutics...
Healthcare Private Placement and M&A Transactions Review Week Ending January 1 2023

Healthcare Private Placement and M&A Transactions Review Week Ending January 1 2023

by Jonathan Hodson-Walker | Jan 5, 2023 | Healthcare

Strategy | Financing Highlight  Private Placement / Financing Transactions NextPoint: The company raised $80 million of venture funding from undisclosed investors on December 19, 2022. The company is a developer of medications intended to expand the benefit of...
Healthcare Private Placement and M&A Transactions Review Week Ending December 18 2022

Healthcare Private Placement and M&A Transactions Review Week Ending December 18 2022

by Jonathan Hodson-Walker | Dec 22, 2022 | Healthcare

Strategy | Financing Highlight – Click on the image below to read our CES Analysis Private Placement / Financing TransactionsHistoSonics: The company raised $100 million of venture funding in a deal led by Johnson & Johnson Innovation – JJDC on...
« Older Entries
Next Entries »

Search

Recent Posts

  • Technology Private Placement and M&A Transactions Review Week Ending May 4, 2025
  • Consumer Private Placement and M&A Transactions Review Week Ending May 4, 2025
  • Healthcare Private Placement and M&A Transactions Review Week Ending May 4, 2025
  • Technology Private Placement and M&A Transactions Review Week Ending April 27, 2025
  • Consumer Private Placement and M&A Transactions Review Week Ending April 27, 2025

Categories

Archives